You're browsing as a guest. Sign in to unlock all features.
VRTX
Vertex Pharmaceuticals·Biotechnology·United States
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases ...
1 Total1 External0 In-site
VRTXVertex Pharmaceuticals
2026-02-17🏥 HealthcarePitch
Externalby Grillo Insights · Substack
Grillo Insights on Vertex Pharmaceuticals (VERTEX PHARMACEUTICALS)
主要经营地
美国
详细的生意模式
生物制药：囊性纤维化现金牛+基因疗法/管线，盈利高但研发与审批决定未来
护城河
✅强 IP 与现金牛业务
✅研发平台与管线选项
⚠️管线成功率与定价/支付
估值水平
FCF/EV 2.4%；EV/EBITDA 21.37x；P/E 30.70x
EV/Market Cap
0.91x
网络观点
🌟作者给出目标价与“强买”，强调核心业务与新疗法机会
⚠️估值偏高且高度依赖管线兑现
AI 的观点
✅业务质量强，但安全边际一般，更像“质量成长”
❌若管线推进不及预期，估值支撑会变弱
🔎核查：CF 产品生命周期、管线里程碑与概率、研发费用趋势、现金使用（回购/并购）
作者简介
Twitter @SuEricGP；专业投资者❌ 否；顶级作者❌ 否；总回报-2.4% (11 trades)